Pathware is creating hardware and software to simplify digital pathology workflows.
Pathware has raised $7.0M in total funding. The most recent round was Series A. The last funding was announced in April 2022.
Pathware's investors include Solas BioVentures, Keiretsu Capital, VentureWell, UnityPoint Health Ventures, TCA Venture Group.
Pathware is headquartered in Golden, United States.
Pathware is creating hardware and software to simplify digital pathology workflows.
Pathware is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pathware — Funding & Investors." VCBacked, April 19, 2022, https://www.vcbacked.co/company/pathware. Accessed September 29, 2026.
VCBacked. (2022). Pathware — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/pathware
{{cite web |title=Pathware — Funding & Investors |url=https://www.vcbacked.co/company/pathware |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated